{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:31:42Z","timestamp":1790098302664,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pompe disease, also known as glycogenosis type II or acid maltase deficiency, is an autosomal recessive disease caused by a deficiency of alpha-glucosidase. The severity depends mainly on the type of mutation, which in turn determines early or late onset; therapy modifies the outcome but does not alter the severity of the disease at presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We present a case report of a male infant, inborn and delivered at a gestational age of 39 weeks. Medical history reveals consanguineous parents with no invasive screening tests performed during pregnancy. They chose not to undergo prenatal screening even though they were aware of the risks associated with their consanguinity. At birth, the newborn was atonic and pale, with a heart rate of 70\u00a0bpm. During resuscitation, an umbilical venous catheter was placed, and three doses of adrenaline and one dose of bicarbonate were administered. At the Neonatal Intensive Care Unit, he underwent therapeutic hypothermia. Echocardiography, performed a few hours later, revealed severe biventricular and septal hypertrophy consistent with non-obstructive hypertrophic cardiomyopathy. During recovery, even after the discontinuation of hypothermia, the newborn exhibited abnormal neurological signs, including axial hypotonia and a tendency to keep his mouth open with tongue protrusion. Given the clinical picture and the early detection of septal and biventricular hypertrophy, genetic testing was performed, revealing a homozygous c.2560\u00a0C\u2009&gt;\u2009T variant in the acid alpha-glucosidase gene (both parents were carriers), described in scientific literature as a class 5 pathogenic variant associated with glycogenosis type II (Pompe disease).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pompe disease is a rare genetic disorder and may be difficult to diagnose at birth. Suspicion should arise in the presence of hypertrophic cardiomyopathy, especially when associated with a history of neonatal asphyxia and abnormal neurological signs. An accurate diagnosis and early treatment are essential to improving the patient\u2019s survival and quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13052-025-02088-3","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T15:36:05Z","timestamp":1755876965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An uncommon case of neonatal asphyxia associated with infantile-onset Pompe disease"],"prefix":"10.1186","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8795-5886","authenticated-orcid":false,"given":"Francesco","family":"Leo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Barchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Balestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Chesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Dio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Garavelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Iughetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Gargano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"2","key":"2088_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HM Van den Hout","year":"2003","unstructured":"Van den Hout HM, Hop W, van Diggelen OP, et al. The natural course of infantile pompe\u2019s disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003;112(2):332\u201340.","journal-title":"Pediatrics"},{"issue":"9","key":"2088_CR2","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3390\/biom10091339","volume":"10","author":"NK Meena","year":"2020","unstructured":"Meena NK, Raben N. Pompe disease: new developments in an old lysosomal storage disorder. Biomolecules. 2020;10(9):1339. https:\/\/doi.org\/10.3390\/biom10091339. Published 2020 Sep 18.","journal-title":"Biomolecules"},{"key":"2088_CR3","doi-asserted-by":"publisher","unstructured":"Gragnaniello V, Pijnappel PWWM, Burlina AP, In't Groen SLM, Gueraldi D, Cazzorla C, Maines E, Polo G, Salviati L, Di Salvo G, Burlina AB. Newborn screening for Pompe disease in Italy: Long-term results and future challenges. Mol Genet Metab Rep. 2022 Oct https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100929","DOI":"10.1016\/j.ymgmr.2022.100929"},{"key":"2088_CR4","doi-asserted-by":"publisher","unstructured":"Howell RR, Byrne B, Darras BT et al. Diagnostic challenges for Pompe disease: an under-recognized cause of floppy baby syndrome. Genet Med. 2006;8(5):289\u2013\u200996. https:\/\/doi.org\/10.1097\/01.gim.0000204462.42910.b8. PMID: 16702878.","DOI":"10.1097\/01.gim.0000204462.42910.b8"},{"key":"2088_CR5","doi-asserted-by":"publisher","unstructured":"Hagemans ML, Winkel LP, Hop WC et al. Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology. 2005;64(12):2139-41. https:\/\/doi.org\/10.1212\/01.WNL.0000165979.46537.56. PMID: 15985590.","DOI":"10.1212\/01.WNL.0000165979.46537.56"},{"key":"2088_CR6","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1002\/humu.20745","volume":"29","author":"M Kross","year":"2008","unstructured":"Kross M, Pomponio RJ, van Vliet L, Palmer RE, Phipps M, Van der Helm R, Halley D, Reuser A. GAA database consortium. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating. Hum Mutat. 2008;29:E13\u201326.","journal-title":"Hum Mutat"},{"key":"2088_CR7","doi-asserted-by":"crossref","unstructured":"Kishnani PS, Hwu WL, Mandel H, Infantile-Onset Pompe Disease Natural History Study Group. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr. 2006;148(5):671\u2013676. doi: 10.1016\/j.jpeds.2005.11.033. PMID: 16737883.","DOI":"10.1016\/j.jpeds.2005.11.033"},{"issue":"11","key":"2088_CR8","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/humu.23878","volume":"40","author":"AJJ Reuser","year":"2019","unstructured":"Reuser AJJ, van der Ploeg AT, Chien YH, et al. GAA variants and pheno- types among 1,079 patients with Pompe disease. Data from the Pompe registry. Hum Mutat. 2019;40(11):2146\u201364. https:\/\/doi.org\/10.1002\/humu.23878.","journal-title":"Hum Mutat"},{"key":"2088_CR9","doi-asserted-by":"publisher","unstructured":"Kishnani PS, Hwu WL, Mandel H, et al. Infantile-Onset Pompe Disease Natural History Study Group. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr. 2006;148(5):671\u2013676. https:\/\/doi.org\/10.1016\/j.jpeds.2005.11.033 PMID: 16737883.","DOI":"10.1016\/j.jpeds.2005.11.033"},{"key":"2088_CR10","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00415-009-5219-y","volume":"256","author":"SM Oba","year":"2009","unstructured":"Oba SM, Shinjo, et al. Pompe disease in a Brazilian series: clinical and molecular analyses with identification of nine new mutations. J Neurol. 2009;256:1881\u201390.","journal-title":"J Neurol"},{"key":"2088_CR11","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1056\/NEJMoa2200587","volume":"387","author":"JL Cohen","year":"2022","unstructured":"Cohen JL, et al. In utero Enzyme-Replacement therapy for Infantile-Onset pompe\u2019s disease. N Engl J Med. 2022;387:2150\u20138. https:\/\/doi.org\/10.1056\/NEJMoa2200587.","journal-title":"N Engl J Med"},{"key":"2088_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3892\/etm.2015.2862","volume":"11","author":"Y Liu","year":"2016","unstructured":"Liu Y, Yang Y, Wang B, et al. Infantile Pompe disease: a case report and review of the Chinese literature. Exp Ther Med. 2016;11:235\u20138.","journal-title":"Exp Ther Med"},{"key":"2088_CR13","doi-asserted-by":"publisher","unstructured":"Burton BK, Kronn DF, Hwu WL, Pompe Disease Newborn Screening Working Group. The initial evaluation of patients after positive newborn screening: Recommended algorithms leading to a confirmed diagnosis of pompe disease. Pediatrics. 2017;140(Suppl 1):S14-S23. https:\/\/doi.org\/10.1542\/peds.2016-0280D. PMID: 29162674.","DOI":"10.1542\/peds.2016-0280D"},{"issue":"1","key":"2088_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/gim.2011.4","volume":"14","author":"YH Messinger","year":"2012","unstructured":"Messinger YH, Mendelsohn NJ, Rhead W, et al. Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease. Genet Med. 2012;14(1):135\u201342. https:\/\/doi.org\/10.1038\/gim.2011.4. PMID: 22237443; PMCID: PMC3711224.","journal-title":"Genet Med"},{"issue":"1","key":"2088_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/JND-190426","volume":"7","author":"SM Salabarria","year":"2020","unstructured":"Salabarria SM, Nair J, Clement N, et al. Advancements in AAV-mediated gene therapy for Pompe disease. J Neuromuscul Dis. 2020;7(1):15\u201331. https:\/\/doi.org\/10.3233\/JND-190426. PMID: 31796685; PMCID: PMC7029369.","journal-title":"J Neuromuscul Dis"},{"key":"2088_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13052-022-01379-3","volume":"48","author":"Xi","year":"2022","unstructured":"Xi, et al. Infantile Pompe disease with intrauterine onset: a case report and literature review. Ital J Pediatr. 2022;48:187. https:\/\/doi.org\/10.1186\/s13052-022-01379-3.","journal-title":"Ital J Pediatr"},{"key":"2088_CR17","doi-asserted-by":"publisher","unstructured":"Kronn DF, Day-Salvatore D, Hwu WL, Pompe Disease Newborn Screening Working Group. Management of Confirmed Newborn-Screened Patients With Pompe Disease Across the Disease Spectrum. Pediatrics. 2017;140(Suppl 1):S24-S45. https:\/\/doi.org\/10.1542\/peds.2016-0280E. PMID: 29162675.","DOI":"10.1542\/peds.2016-0280E"},{"issue":"3","key":"2088_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1203\/PDR.0b013e3181b24e94","volume":"66","author":"PS Kishnani","year":"2009","unstructured":"Kishnani PS, Corzo D, Leslie ND, et al. Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease. Pediatr Res. 2009;66(3):329\u201335. https:\/\/doi.org\/10.1203\/PDR.0b013e3181b24e94. PMID: 19542901; PMCID: PMC3129995.","journal-title":"Pediatr Res"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02088-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-02088-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02088-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:20:10Z","timestamp":1757416810000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-02088-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2088"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-02088-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6271024\/v1","asserted-by":"object"}]},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"260"}}